Guidance for FDA staff and industry : marketed unapproved drugs, compliance policy guide.

Saved in:

Bibliographic Details
Imprint:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2006]
Description:	1 online resource (i, 12 pages)
Language:	English
Subject:	Center for Drug Evaluation and Research (U.S.) Drugs -- United States -- Marketing -- Government policy. Drug approval -- Government policy -- United States.
Format:	E-Resource U.S. Federal Government Document Book
URL for this record:	http://pi.lib.uchicago.edu/1001/cat/bib/7894191

Hidden Bibliographic Details
Varying Form of Title:	Marketed unapproved drugs, compliance policy guide
Notes:	"Sec. 440.100 marketed new drugs without approved NDAs or ANDAs." "Compliance." "June 2006."
GPO item no.:	0499-P (online)
Govt.docs classification:	HE 20.4708:M 34

Similar Items